论文部分内容阅读
目的:评估复方苦参注射液对老年晚期肿瘤患者的治疗效果。方法:老年晚期恶性肿瘤患者60例随机分为两组,治疗组(30例)在常规对症治疗的同时予复方苦参注射液治疗,而对照组(30例)予常规对症治疗。结果:治疗组80%患者KPS评分提高,且疼痛总缓解率达83%,而对照组均无明显改善;治疗组IL-2值明显升高,IL-6值明显下降(与治疗前比较,P<0.05),并且较对照组IL-2值仍升高,IL-6值仍下降(与对照组比较,P<0.05)。结论:复方苦参注射液对老年晚期肿瘤患者生活质量改善、疼痛缓解以及免疫调节等方面均有积极的治疗意义。
Objective: To evaluate the curative effect of Compound Kushen Injection on elderly patients with advanced cancer. Methods: Sixty elderly patients with advanced malignant tumors were randomly divided into two groups. The treatment group (30 cases) was treated with Fufang Kushen injection while the control group (30 cases) were treated with conventional symptomatic treatment. Results: In the treatment group, the KPS score was increased and the total pain relief rate was 83%, while the control group had no significant improvement. The IL-2 level in the treatment group was significantly increased and the IL-6 level was significantly decreased (compared with before treatment, P <0.05). IL-2 level was still higher and IL-6 level was still lower than the control group (P <0.05 compared with the control group). Conclusion: Compound Kushen injection has a positive therapeutic effect on improvement of quality of life, pain relief and immune regulation in elderly patients with advanced cancer.